Market Cap (In CNY)
8.38 Billion
Revenue (In CNY)
360.25 Million
Net Income (In CNY)
161.55 Million
Avg. Volume
2.46 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 20.27-53.18
- PE
- -
- EPS
- -
- Beta Value
- -0.404
- ISIN
- CNE1000050F4
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Jingsong Zhou
- Employee Count
- -
- Website
- https://www.yizhongpharma.com
- Ipo Date
- 2021-09-09
- Details
- Shanghai Yizhong Pharmaceutical Co., Ltd. engages in the development of anti-tumor drugs and related products in China. It develops a dosage form of paclitaxel, an anti-tumor chemotherapeutic. The company was founded in 2009 and is based in Shanghai, China.
More Stocks
-
300786
-
600302
-
SYSCHEMSyschem (India) Limited
SYSCHEM
-
BTB-UN
-
CHCL
-
MMNGFMetallic Minerals Corp.
MMNGF
-
TRINITYLEATrinity League India Limited
TRINITYLEA
-
NOBDFNorth Bud Farms Inc.
NOBDF